Brief: Trevi Therapeutics To Present Two Phase 2a River Trial Posters At ERS Congress 2025
18/09/2025 12:49
Sept 18 (Reuters) - Trevi Therapeutics Inc TRVI.O: TREVI THERAPEUTICS ANNOUNCES TWO POSTERS FROM THE PHASE 2A RIVER TRIAL DATA WILL BE FEATURED AT THE EUROPEAN RESPIRATORY SOCIETY (ERS) CONGRESS 2025 Source text: ID:nPnc2ZgCca Further company coverage: TRVI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Trevi Therapeutics
See all newsTrevi Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Trevi Therapeutics Q2 net loss widens on higher R&D costs
Brief: Trevi Therapeutics Q2 Net Income USD -17.797 Million
Trevi Therapeutics Q1 net loss widens as R&D costs rise
Brief: Trevi Therapeutics Q1 Net Income USD -13.192 Million